Posts Tagged ‘ Prolift ’

FDA Rules To Reclassify POP Vaginal Mesh as High Risk!

Jan 4th, 2016 | By
Uphold, Boston Scientific, still on the market

January 4, 2016 ~ An expert panel convened by the U.S. Food and Drug Administration (FDA) decided in September 2011 that mesh used to treat pelvic organ prolapse (POP) should be reclassified as high risk from its moderate risk (Class II) status. Today, the FDA announced POP mesh would finally be reclassified as a high
[continue reading…]



Prolift Pelvic Mesh Found Defectively Designed, Plantiff Awarded $5.5 Million, Punitives to be Determined

Dec 21st, 2015 | By
J&J logo

Mesh News Desk, December 21, 2015 ~ A Philadelphia jury today ruled Johnson & Johnson (J&J) must pay a mesh-injured woman $5.5 million in compensatory damages for its negligence over the defectively designed Prolift pelvic mesh. The jury will return for deliberations Tuesday over punitive damages which could add millions to the verdict in a
[continue reading…]



Jurors Begin Deliberating Philadelphia Prolift Pelvic Mesh Case

Dec 16th, 2015 | By
Prolift on eBay July 2013

The two-week trial of Hammons  v. Ethicon case went to the jury Friday in the first pelvic mesh tried in Pennsylvania. The Indiana woman, Patricia Hammons, filed a product liability case against Ethicon, a subdivision of Johnson & Johnson over a Prolift pelvic mesh she received to treat incontinence in 2009.  (Case No. 130503913). The
[continue reading…]



Doctor Directory: Miklos & Moore Talk Transvaginal Mesh

Apr 24th, 2015 | By
m and m graphic

As part of a series, Mesh News Desk interviews doctors who are dealing with mesh complications. This month it is Miklos & Moore and their http://www.meshsurgeons.com/, International Urogynecology Associates, based in Atlanta, Georgia. A large part of their practice is now dealing with complications from polypropylene transvaginal mesh implants. These are the voices who make
[continue reading…]



*New* New Brunswick Today Covers J&J Upcoming Shareholders Meeting

Apr 14th, 2015 | By
State Theatre, New Brunswick, NJ, Locations of this year's shareholder's meeting.

Thanks to reporter David Schatz of New Brunswick Today for the reminder about next week’s Johnson & Johnson shareholder’s meeting. Included in the story is a link to Mesh News Desk and coverage of those We Are Mesh Survivors members who attended last year’s event at the Hyatt Regency, directly across from J&J headquarters. Three
[continue reading…]



Defense Granted Punitive Motion in J&J Pelvic Mesh Case

Jan 20th, 2015 | By
mallet and money

The pelvic mesh death case of Budke v. Ethicon continued Monday in a Camden Co. Missouri courtroom with the defense granted its motion to deny punitive damages to the plaintiffs.   Last Friday, attorneys for  Johnson & Johnson, the parent company of Ethicon, requested that punitive damages be denied and the case be thrown out
[continue reading…]



Juror No Show Slows Contentious Pelvic Mesh Trial

Jan 9th, 2015 | By
christmans jan 2014 two daughters crisper

Budke Day Two – No Show Juror Things got off to a slow start on Thursday morning because one of the 16 jurors, a young man who appeared to be a teenager, was missing in action. Since the jury pool would eventually be narrowed to 12, talk was that the proceedings could continue without him. 
[continue reading…]



Grey Haze Over Lake of the Ozarks as Prolift Pelvic Mesh Death Case Begins

Jan 7th, 2015 | By
Camden Co courthouse

It is grey and 13 degrees F. today in this small town of Camdenton, Missouri as the first day of the Budke v Ethicon defective product case gets underway.  The plaintiff in this case will not be here.   Joan Budke, 77, died from her injuries sustained from the Prolift mesh made by J&J’s Ethicon
[continue reading…]



Top 10 Myths Woman are Told Today about Pelvic Mesh

Dec 17th, 2014 | By

Mesh News Desk readers frequently share what they’ve been told during the consultation process with a doctor who is encouraging them to have a mesh implant as a treatment for incontinence or prolapse.  Unfortunately the stories have not changed much since this story first ran in April. If you have been diagnosed with incontinence or
[continue reading…]



FAVORABLE JURY VERDICTS CONTINUE IN TRANSVAGINAL MESH (TVM) LITIGATION—IS AMS WATCHING?

Dec 11th, 2014 | By

By Dan C. Bolton, Of Counsel, Keller, Fishback & Jackson LLP                 In recent months, Endo Pharmaceuticals made several announcements concerning global settlements in the transvaginal mesh litigation against American Medical Systems (AMS) pending before Judge Goodwin in federal district court in West Virginia (MDL 2325).  Based on the numbers of women participating, the AMS
[continue reading…]